Opengear expands Europe reach with Ingram Micro deal
Opengear, a Digi International company (NASDAQ:DGII), signed its first pan-European distribution agreement with Ingram Micro to expand access to its out-of-band management solutions across Europe.
Todas as matérias desta seção, das mais recentes às mais antigas — página 43 de 371.
Opengear, a Digi International company (NASDAQ:DGII), signed its first pan-European distribution agreement with Ingram Micro to expand access to its out-of-band management solutions across Europe.
InterGroup (NASDAQ:INTG) reported fiscal 2026 financial results, returning to GAAP profitability as improvements in its hotel operations contributed to stronger performance.
TC Energy (NYSE:TRP) announced that it will move forward with Coastal GasLink Phase 2 after LNG Canada’s expansion investment decision satisfied the required project conditions
MongoDB (NASDAQ:MDB) shares fell more than 20% after CEO and president Chirantan “CJ” Desai resigned to join Meta Platforms.
OMS Energy Technologies (NASDAQ:OMSE) secured US$9.4 million in new orders from Saudi Aramco and Pertamina Hulu Rokan for oilfield equipment and components.
FTAI Aviation (NASDAQ:FTAI) acquired 27 Boeing 737-700 aircraft from WestJet, with the purchase divided between its 2026 SPV investment vehicle and Aerospace Products business.
FTAI Infrastructure (NASDAQ:FIP) subsidiary Jefferson agreed to acquire crude oil logistics assets from a USD Group subsidiary for approximately $255 million in cash.
Psyence BioMed (NASDAQ:PBM) announced that its Texas subsidiary signed a binding term sheet with PsyLabs for proposed exclusive U.S. ibogaine rights.
Eldorado Gold (NYSE:EGO) completed the permanent connection of its Skouries mine in northern Greece to the national power grid after final inspections and approvals.
Adicet Bio (NASDAQ:ACET) reported Phase 1 safety and efficacy data for prulacabtagene leucel (prula-cel) in patients with systemic lupus erythematosus with or without lupus nephritis.
Grafa is streaming live from Marina Bay Sands on 7 and 8 October. Watch right here as we sit down with the founders, investors and builders shaping where crypto goes next.
BlossomHill Therapeutics (NASDAQ:BLSM) presented preclinical findings for BH-501284, an investigational pan-KRAS inhibitor, showing activity across KRAS-mutant cancer models.
OSI Systems (NASDAQ:OSIS) received orders of approximately $7 million from a leading industrial controls original equipment manufacturer for electronic sub-assemblies.
Merck (NYSE:MRK) entered an exclusive global license agreement with SciBrunch Therapeutics for SPR2015, a preclinical oral KRAS G12D inhibitor being developed for potential cancer treatments.
SCYNEXIS (NASDAQ:SCYX) secured a contract with the Biomedical Advanced Research and Development Authority to support development of SCY-247, with potential funding of up to approximately $214 million.
Valley National Bancorp (NASDAQ:VLY) agreed to acquire Bluevine for approximately $340 million in a cash-and-stock transaction expected to include about 75% cash and 25% Valley common stock.
Soluna Holdings (NASDAQ:SLNH) amended its agreement with Bitdeer Technologies Group (NASDAQ:BTDR) subsidiary Dory Creek to expand Bitcoin mining operations at Soluna’s Project Kati 1 in South Texas.
TOYO (NASDAQ:TOYO) signed binding U.S. solar module supply agreements worth approximately $240 million with multiple U.S. customers since mid-June 2026.
Arvinas (NASDAQ:ARVN) dosed the first participant in a Phase 1/2 trial of ARV-6723, an investigational oral immuno-oncology candidate designed to degrade HPK1 in adults with advanced solid tumors.
Cosmos Health (NASDAQ:COSM) reported more than $20 million in implied revenue from Cana Laboratories’ contract manufacturing pipeline, based on management estimates over the expected duration of agreements.
Foresight Autonomous Holdings (NASDAQ:FRSX) signed a non-binding term sheet to acquire a 50.01% stake in a company advancing two data center projects in Poland.
TOYO (NASDAQ:TOYO) said it expects positive EBITDA for the second half of 2026 while withholding specific financial guidance due to ongoing U.S. trade and regulatory uncertainty.
AbbVie (NYSE:ABBV) received U.S. Food and Drug Administration approval for JUVMO (tavapadon) tablets to treat adults with Parkinson’s disease.
Maris-Tech (NASDAQ:MTEK) received a US$10 million order to develop and supply video systems for next-generation manned airborne platforms under a multi-year project with Magam Safety.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade